Citation:Horwhat JD, Baroni D, Maydonovitch C, Osgard E, Ormseth E, Rueda-Pedraza E, et al 2007

From Cancer Guidelines Wiki

Citation


Horwhat JD, Baroni D, Maydonovitch C, Osgard E, Ormseth E, Rueda-Pedraza E, et al. Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data. Am J Gastroenterol 2007 Mar;102(3):497-506 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/17156135.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the incidence of neoplasia in patients with BO?Associate Professor Freddy Sitascompleted
Are there any medical or surgical interventions that cause regression of BO?Dr Adrian Chung MBBS, BMed Sci, FRACPcompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Are there groups of patients with BO that can be discharged from surveillance?